Richard E. Chipkin - Concepedia

Author

Richard E. Chipkin

Bloomfield College

Also Known As

R E Chipkin, R. Chipkin, R. E. CHIPKIN, R. E. Chipkin, R.E Chipkin, R.E. Chipkin, Richard Chipkin, Richard E. Chipkin

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Bloomfield College Psyadon Pharmaceuticals (United States)University of California San Diego University of Colorado Denver Emory University

About

Richard E. Chipkin is an author at Bloomfield College specializing in neuropharmacology, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	32	889
2	Health Sciences	11	11	264
3	Social Sciences	9	9	328
4	Natural Sciences	5	5	221
5	Allergy	1	1	13

Richard E. Chipkin

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity. Richard E. Chipkin, Louis C. Iorio, Vicki L. Coffin, Journal of Pharmacology and Experimental Therapeutics	1988	183
A D1 Receptor Antagonist, Ecopipam, for Treatment of Tics in Tourette Syndrome Donald L. Gilbert, Cathy L. Budman, Harvey S. Singer, Clinical Neuropharmacology	2014	101
Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic. Richard E. Chipkin, Joel G. Berger, William Billard, Journal of Pharmacology and Experimental Therapeutics	1988	93
Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors. Vicki L. Coffin, Miklos B. Latranyi, Richard E. Chipkin Journal of Pharmacology and Experimental Therapeutics	1989	87
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study Donald L. Gilbert, Tanya K. Murphy, Joseph Jankovic, Movement Disorders	2018	80
Synthesis and receptor affinities of some conformationally restricted analogs of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol Joel G. Berger, Wei K. Chang, John W. Clader, Journal of Medicinal Chemistry Dopamine D1 AntagonistReceptor AffinitiesMedicinal ChemistryAxial SubstituentsNeurochemistry	1989	77
Serotonergic component of SCH 23390: In vitro and in vivo binding analyses Robert D. McQuade, David Ford, Ruth A. Duffy, Life Sciences Vivo Binding AnalysesMolecular NeuroscienceBiochemistryMedicineNatural Sciences	1988	73
Comparisons between warm and cold water swim stress in mice Patricia OʼConnor, Richard E. Chipkin Life Sciences BiologyPhysiological ResearchEnvironmental StressBehavioral NeurosciencePhysiology	1984	71
The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal, ventral medulla and amygdala Nayef R. F. Al-Rodhan, Richard E. Chipkin, Tony L. Yaksh Brain Research Pain MedicineVentral MedullaMolecular PainSocial SciencesMolecular Pharmacology	1990	66
D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy Richard E. Chipkin, Robert D. McQuade, Louis C. Iorio Pharmacology Biochemistry and Behavior Molecular NeuroscienceBehavioral NeuroscienceNeuroanatomyMedicineNeurotransmitter	1987	48

Page 1